# Exagen Inc. to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/XGN/exagen-inc-to-participate-in-upcoming-investor-conferences
Ticker: XGN
Company: Exagen
Source: Exagen
Published: 2026-03-03 14:00 EST
Original Source URL: https://investors.exagen.com
## Summary

CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences: KeyBank Capital Markets Healthcare Forum - Virtual Date: March 17, 2026 Participation:

## Article Body
CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences: KeyBank Capital Markets Healthcare Forum - Virtual Date: March 17, 2026 Participation:
## Recent Company News
- 2026-06-01 13:00 EST — [Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus](https://biopharmsignal.com/news/XGN/exagen-announces-publication-of-systematic-review-confirming-robust-real-world-performance-of-avise-lupus) — Source: Exagen
- 2026-05-11 12:00 EST — [Exagen Inc. Reports First Quarter 2026 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-first-quarter-2026-results) — Source: Exagen
- 2026-04-27 13:00 EST — [Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026](https://biopharmsignal.com/news/XGN/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026) — Source: Exagen
- 2026-03-10 12:00 EST — [Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-strong-fourth-quarter-and-full-year-2025-results) — Source: Exagen
- 2026-03-03 14:00 EST — [Exagen Inc. to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/XGN/exagen-inc-to-participate-in-upcoming-investor-conferences) — Source: Exagen
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)